Gross profit increased 93% from Q1 as operating expenses declined 17%, demonstrating strong sequential operating performance
Q2 net sales reached a record $5.23 million, up 27% year-over-year and 58% sequentially
Read More
Record Quarterly Gross Margin of 34.9%; Record Adjusted EBITDA¹ of $3.7 Million, Up 27% Year over Year; Quarterly revenue of $17.7 million
Amazon Commercial Agreement and ElvaPulse™ 1500 Launch Position Company for Expanded Growth Opportunities
Read More
HIGHLIGHTS
‘Phase 2' reverse circulation (RC) and diamond drilling (DD) Resource upgrade drilling complete, totalling 38,760m RC and DD drilling and 311 holes during intensive 5 month, 4 drilling rig campaign
Pre-Feasibility Study (PFS) underway for large-scale gold production, targeting Q1 CY27 publication
A new facility puts Colz Electric within faster reach of homes and businesses. While a relaunched website and upgraded service standards round out the company's biggest expansion since 2013.
Read More
New first-of-its-kind K9 protocol gives law enforcement agencies a standardized rapid-response framework to decontaminate K9s, their handlers, and police vehicles, from dangerous narcotics
Read More
A new facility puts Colz Electric within faster reach of homes and businesses. While a relaunched website and upgraded service standards round out the company's biggest expansion since 2013.
Read MoreSingle-tranche financing carries one full warrant per Unit at $0.12, issues less than half the Units contemplated under the previously announced offering, creates no freely tradeable stock at closing, and is expected to include insider participation. Proceeds are directed to the next phase of exploration at the Mesa Arc Project (New Mexico) and the Green River Project (Utah). The Company's previously announced offering, comprising a LIFE Financing and a concurrent financing, has been cancelled due to market conditions.
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
Read More
Offering nearly 3 MWh of energy with up to 7 MW of continuous power for demanding data center, AI infrastructure and critical-power applications
Initial deliveries targeted for Q2 2027 from Electrovaya's Jamestown, NY manufacturing facility, designed to support 48E Investment Tax Credit eligibility
Worksport will host its Q2 2026 earnings conference call on August 11, 2026, at 4:30 p.m. ET, following market close, with an investor townhall immediately afterward featuring CEO commentary, business updates, and shareholder Q&A.
Read MoreNews Release Highlights:
U.S. FDA Pharmacy Compounding Advisory Committee recommends the inclusion of six peptide substances, including BPC-157, KPV, TB-500, MOTS-c, Epitalon and Semax, on the FDA's 503A Bulks List, representing a significant step in the FDA's ongoing regulatory review process for these peptide substances.
Vanta has established a strategic operating framework supporting its contemplated U.S. peptide platform, including telehealth-enabled commercialization, FDA-registered compounding pharmacy coordination, peptide manufacturing and fulfillment capabilities, and compliant payment processing infrastructure.
Vanta continues advancing its strategy to build an integrated U.S.-focused consumer health sciences platform combining contemplated peptide therapies with its existing nutraceutical and premium functional hydration portfolio, positioning the Company to participate in the longevity and preventative wellness market.